Selank 10mg
Tuftsin-Derived Anxiolytic for Anxiety and Cognitive Research
Selank is the base tuftsin-derived heptapeptide developed in Russia with documented anxiolytic, nootropic, and immune-modulating properties. Registered as an approved anxiolytic drug in Russia and Ukraine.
Tuftsin-Derived Anxiolytic for Anxiety and Cognitive Research
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) modulates the GABA-A receptor complex and enhances BDNF expression in the hippocampus, producing anxiolytic effects comparable to benzodiazepines without dependence or cognitive impairment.
As one of the most studied compounds in the longevity research space, Selank has attracted sustained scientific interest across Anxiety research, Cognitive enhancement, Immune system studies. Peer-reviewed evidence indicates that registered drug in Russia for generalized anxiety, which has positioned Selank as a reference standard for researchers exploring anxiety research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
Selank Documented Benefits: 3 Documented Mechanisms
Anxiolytic Without Dependence
Reduces anxiety comparable to diazepam in animal models without tolerance or addiction risk.
BDNF Enhancement
Upregulates hippocampal BDNF, supporting neuroplasticity and memory consolidation.
Immune Modulation
Regulates IFN and interleukin expression, balancing immune responses under stress.
How Selank Works: Molecular Mechanism & Pathway
Tuftsin (Thr-Lys-Pro-Arg) analogue modulating GABA-A receptors and enhancing BDNF expression to reduce anxiety and support cognitive function.
The 3 primary research pathways identified for Selank — Anxiolytic Without Dependence, BDNF Enhancement, Immune Modulation — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that anxiolytic without sedation in clinical studies, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, Selank's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
Selank is routinely studied alongside DSIP and NA-Selank in longevity-focused compound panels. Researchers investigating anxiety research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that enhances BDNF by up to 1.3x in rat hippocampus has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All Selank research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Registered drug in Russia for generalized anxiety
- Anxiolytic without sedation in clinical studies
- Enhances BDNF by up to 1.3x in rat hippocampus
Ideal For
- Anxiety research
- Cognitive enhancement
- Immune system studies
- Nootropic protocols
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on Selank. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Registered drug in Russia for generalized anxiety
Anxiolytic without sedation in clinical studies
Enhances BDNF by up to 1.3x in rat hippocampus
Third-Party Verified Every Batch
Each vial of Selank is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
